Cell culture media development: from project scope to validated formulation
Cell culture media development is the process of designing, testing and refining the formulation used to support cells in a particular culture process. The aim is not simply to find a recipe that supports growth. It is to establish how that recipe performs against the needs of the cells, the process and the intended application.
At Multus, a MediOP™ Project connects formulation design with robotic preparation, cell culture and analytics in a closed loop. This guide explains how that process runs, what validation needs to establish and what a formulation handover includes.
Start with the cells, process and success criteria
The first step is to agree the scope. Multus’s project process starts with the cell line, the culture process and the criteria that will determine whether a formulation meets the brief.
For biopharma developers, CDMOs and media suppliers, the relevant question is how media fits the process rather than whether a formulation performs well in isolation. Cellular agriculture and materials applications bring different requirements, but the same principle applies: development needs a defined context.
Before testing begins, a useful project brief sets out:
- The cell type and culture conditions in which the media will be used.
- The current medium or feed that will serve as the benchmark.
- The performance measures and ingredient constraints that guide formulation design.
- The cost, quality and supply considerations that matter for the intended use.
These are points to agree with the project team, not a universal specification. Success criteria and the validation plan should reflect the particular application.
Design formulations and test them in a closed loop
The MediOP™ platform brings models and laboratory experiments into one iterative process. Predictions guide which formulations to test; measured responses then inform the next round. A model’s recommendation is a candidate for an experiment, not a substitute for experimental evidence.
The loop has five stages:
- Design. The algorithm selects candidate formulations against the cells, goals and ingredient constraints in the project brief.
- Automate. Robotic liquid handling prepares formulations in parallel.
- Culture. Cells are cultured across the selected formulations, with integrated incubation, feeding and plate handling.
- Read. Cellular analytics capture performance data from the experiments.
- Learn. Models analyse how cells respond across conditions and select informative conditions for the next cycle.
This integration matters because the design process depends on the evidence generated by the experiments. Each cycle connects the ingredient combinations being tested to observed cellular performance.
Benchmark the leading formulations
Screening identifies candidates worth investigating further. Validation asks whether those candidates meet the agreed criteria when compared with the current media.
In Multus’s project process, leading formulations are benchmarked against that starting point before delivery. The comparison needs to be interpreted within the conditions in which it was run. A result in one cell type or culture format should not be treated as proof of performance in another.
When reviewing results, ask which formulation and benchmark were compared, which measurements were used and which culture conditions were tested. Also distinguish what has been demonstrated from what still requires evaluation in the intended process.
Read formulation outcomes in context
Development outcomes are project-specific. A formulation may be assessed against performance, cost and quality together; the balance is set by the brief rather than by a single general claim.
Multus’s published CHO media development case study illustrates this approach. It describes feed formulation work for CHO DG44 cells, with antibody expression, growth, viability and raw material cost considered together. It reports validation across microscale and shake flask formats.
That study is evidence for the work and conditions it describes, not a forecast for a new project. The relevant lesson is the connection between a defined objective, experimental measurements, iterative design and validation of selected candidates.
Deliver the formulation and its technical context
The delivery stage of a MediOP™ Project includes the formulation, a technical package and a supply route. The recipe is therefore one part of the handover, alongside the information needed to understand the development work and discuss its use.
The Multus portfolio distinguishes focused optimisation from full de novo development. The appropriate route depends on whether the task is to refine an existing formulation or explore a new one; scope and timing should be agreed for the individual project.
Preparing for a media development discussion
Bring a description of the cells and process, the current medium or feed, the problem you want to address and any ingredient or supply constraints. Identify what a useful outcome would look like and where additional testing may be needed.
Talk to Multus’s scientists about scoping a MediOP™ Project, or explore the platform to see how design and laboratory testing work together.